TOOKER ADIN M 4
4 · HARTFORD INSURANCE GROUP, INC. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Hartford (HIG) President Adin M. Tooker Exercises Options, Sells Shares
What Happened
- Adin M. Tooker, President of Hartford Insurance Group (HIG), exercised 8,307 stock options at $53.81 per share (cost ~$447,000) on Feb 25, 2026 and immediately sold those 8,307 shares in an open‑market transaction at $140.54 per share for proceeds of ~$1,167,466. The transactions were effected pursuant to a Rule 10b5‑1 trading plan adopted Aug 25, 2025 (footnote F1).
- On Feb 24, 2026 Mr. Tooker was also granted 28,982 derivative shares (option award) at $0.00 exercise price (reported as an award/derivative).
Key Details
- Transaction dates/prices: Feb 24, 2026 (grant of 28,982 derivative shares); Feb 25, 2026 (exercise 8,307 @ $53.81; sale 8,307 @ $140.54).
- Cash flow: exercise cost ≈ $447,000; sale proceeds ≈ $1,167,466.
- Vesting/eligibility notes: one-third of the options enabling this exercise became exercisable on Feb 25, 2026 per the filing (footnote F10). The Feb 24, 2026 grant vests over three years (one‑third on Feb 24, 2027, then 2028 and 2029) per footnote F2.
- Plan/authorization: sale was executed under a pre-established Rule 10b5‑1 plan adopted Aug 25, 2025 (footnote F1).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Filing timeliness: report filed Feb 26, 2026 for transactions on Feb 24–25, 2026 (no late‑filing flag indicated).
Context
- This was effectively a cashless exercise: options were exercised and the resulting shares were sold the same day, which is a common way executives realize gains and may be set up in advance via trading plans. The presence of a 10b5‑1 plan indicates the sales were pre‑scheduled and not ad hoc.
- The grant of 28,982 derivative shares is a compensation award subject to multi‑year vesting; such grants do not by themselves signal immediate buying/selling intent.
Insider Transaction Report
Form 4
TOOKER ADIN M
President
Transactions
- Exercise/Conversion
Common Stock
2026-02-25$53.81/sh+8,307$447,000→ 46,515.27 total - Sale
Common Stock
[F1]2026-02-25$140.54/sh−8,307$1,167,466→ 38,208.27 total - Award
Stock Option
[F2]2026-02-24+28,982→ 28,982 totalExercise: $140.54Exp: 2036-02-24→ Common Stock (28,982 underlying) - Exercise/Conversion
Stock Option
[F3]2026-02-25−8,307→ 8,307 totalExercise: $53.81Exp: 2028-02-27→ Common Stock (8,307 underlying)
Holdings
- 26,687
Stock Option
[F4]Exercise: $49.01Exp: 2029-02-26→ Common Stock (26,687 underlying) - 25,202
Stock Option
[F5]Exercise: $51.87Exp: 2031-02-23→ Common Stock (25,202 underlying) - 24,094
Stock Option
[F6]Exercise: $55.27Exp: 2030-02-25→ Common Stock (24,094 underlying) - 24,155
Stock Option
[F7]Exercise: $69.41Exp: 2032-02-23→ Common Stock (24,155 underlying) - 24,301
Stock Option
[F8]Exercise: $78.28Exp: 2033-02-28→ Common Stock (24,301 underlying) - 16,492
Stock Option
[F9]Exercise: $95.74Exp: 2034-02-27→ Common Stock (16,492 underlying) - 25,488
Stock Option
[F10]Exercise: $116.41Exp: 2035-02-25→ Common Stock (25,488 underlying)
Footnotes (10)
- [F1]The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F10]One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
- [F2]One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
- [F3]The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
- [F4]The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
- [F5]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
- [F6]The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
- [F7]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
- [F8]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
- [F9]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
Signature
Anthony J. Salerno, Jr., Attorney-in-Fact|2026-02-26